OTCMKTS:ENZN - Enzon Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.2550 -0.01 (-3.77 %)
(As of 08/21/2018 04:00 PM ET)
Previous Close$0.26
Today's Range$0.2515 - $0.26
52-Week Range$0.03 - $0.40
Volume9,000 shs
Average Volume45,769 shs
Market Capitalization$11.50 million
P/E Ratio2.89
Dividend YieldN/A
Beta0.87
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Receive ENZN News and Ratings via Email

Sign-up to receive the latest news and ratings for ENZN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
SymbolOTCMKTS:ENZN
CUSIP29390410
Phone732-980-4500

Debt

Debt-to-Equity RatioN/A
Current Ratio19.11
Quick Ratio19.11

Price-To-Earnings

Trailing P/E Ratio2.89
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.38 million
Price / Sales1.35
Cash Flow$0.1209 per share
Price / Cash2.11
Book Value$0.21 per share
Price / Book1.21

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$5.44 million
Net Margins43.10%
Return on Equity1.17%
Return on Assets1.12%

Miscellaneous

Employees5
Outstanding Shares44,220,000
Market Cap$11.50 million

Enzon Pharmaceuticals (OTCMKTS:ENZN) Frequently Asked Questions

What is Enzon Pharmaceuticals' stock symbol?

Enzon Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ENZN."

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals Inc (OTCMKTS:ENZN) issued its quarterly earnings data on Wednesday, August, 10th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company earned $2.27 million during the quarter. Enzon Pharmaceuticals had a return on equity of 1.17% and a net margin of 43.10%. View Enzon Pharmaceuticals' Earnings History.

When is Enzon Pharmaceuticals' next earnings date?

Enzon Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, August, 23rd 2018. View Earnings Estimates for Enzon Pharmaceuticals.

Who are some of Enzon Pharmaceuticals' key competitors?

Who are Enzon Pharmaceuticals' key executives?

Enzon Pharmaceuticals' management team includes the folowing people:
  • Mr. Andrew Rackear, CEO & Sec. (Age 64)
  • Mr. Richard L. Feinstein, VP of Fin. & CFO (Age 75)

Has Enzon Pharmaceuticals been receiving favorable news coverage?

News articles about ENZN stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Enzon Pharmaceuticals earned a news and rumor sentiment score of 0.02 on Accern's scale. They also assigned news coverage about the biotechnology company an impact score of 45.58 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Enzon Pharmaceuticals.

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Enzon Pharmaceuticals' stock price today?

One share of ENZN stock can currently be purchased for approximately $0.2550.

How big of a company is Enzon Pharmaceuticals?

Enzon Pharmaceuticals has a market capitalization of $11.50 million and generates $8.38 million in revenue each year. Enzon Pharmaceuticals employs 5 workers across the globe.

How can I contact Enzon Pharmaceuticals?

Enzon Pharmaceuticals' mailing address is 20 Commerce Drive Suite 135, Cranford NJ, 07016. The biotechnology company can be reached via phone at 732-980-4500 or via email at [email protected]


MarketBeat Community Rating for Enzon Pharmaceuticals (OTCMKTS ENZN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Enzon Pharmaceuticals and other stocks. Vote "Outperform" if you believe ENZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENZN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel